Novartis released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, ...

Representing 92% of Q1 2025 total revenue, up by c. 150 basis points versus 91% in Q1 2024, recurring revenue reached € 43.9 ...

Read about Iridium's 5 percent growth in fiscal 2025 first quarter revenue and learn more about the financial results of its ...

Net profit before tax rises 33% YoY to AED 2.2 billion with net profit after tax rising 22% YoY to AED 1.9 billion. 1; Robust ...